ADAM POWERS: Open Payments
NPI 1679231625 · TYRONE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$432 in 21 payments from 10 companies in 2025. Trend: 2023 $314 · 2024 $530 · 2025 $432
Food & beverage: $432
| Company | Payments | Amount |
|---|---|---|
| Foundation Fusion Solutions, LLC | 5 | $145 |
| Collegium Pharmaceutical, Inc. | 4 | $82 |
| Medtronic, Inc. | 3 | $54 |
| Virtus Pharmaceuticals LLC | 2 | $34 |
| Averitas Pharma Inc. | 1 | $26 |
| SI-BONE, INC. | 1 | $23 |
| SPR Therapeutics, Inc | 2 | $22 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
| ABBVIE INC. | 1 | $14 |
| Ferring Pharmaceuticals Inc. | 1 | $13 |
Products named: Belbuca, INCEPTIV, LEVORPHANOL TARTRATE, QUTENZA, SPRINT PNS System, XTAMPZA, RELISTOR, QULIPTA.
Industry payments across PA — which companies pay providers there.
